A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients
about
Reliable genotypic tropism tests for the major HIV-1 subtypesHIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants.Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropismFrequent detection of CXCR4-using viruses among Brazilian blood donors with HIV-1 long-standing infection and unknown clinical stage: Analysis of massive parallel sequencing dataSensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects.Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppressionHIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to MaravirocClinical implications of HIV-1 minority variantsDeep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Profile of HIV type 1 coreceptor tropism among Kenyan patients from 2009 to 2010Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.Clinical relevance of target identity and biology: implications for drug discovery and development.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.Deep sequencing: becoming a critical tool in clinical virology.Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor useResults of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study.Development of maraviroc, a CCR5 antagonist for treatment of HIV, using a novel tropism assay.Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testing.Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients.HIV-1 drug-resistant minority variants: sweating the small stuffSensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing
P2860
Q30372085-84378B0A-3072-4DC1-833F-D5DA4E3AEF33Q30836893-A125717C-9C80-49E0-8D04-B7F6CA8EE1ADQ31026698-A8706415-A4BE-4EA1-BFA5-8BDED78E5B1EQ31044033-9F9AE9B4-AEC3-47FB-B2F9-06454E5C9538Q33622927-612CEB5A-BAB7-4F70-8AC6-F0D6335F32A8Q33712327-BB852261-F884-452D-B8CE-B26A7E321B52Q35491675-734D535D-CFAD-4772-948F-516F64FF8456Q35662019-990F072F-5B77-42AB-9F50-C95D605A41C5Q36811249-5D629613-1DFE-4F1F-A80F-DA19D3C170B6Q36827155-12EF0AB7-7FD2-4725-B372-A54BDC5E1438Q36933330-7741B8F9-4689-45BC-9489-5A81EFFEE89CQ37025683-B9EB717A-467C-47DF-BAD8-836A1869020DQ37335890-4999EFF9-9DE6-4D8F-8872-AF396F36EBACQ37525642-B6278988-B5DF-476A-82F7-C93B7386EFE1Q37547823-16188029-BD8D-4541-A67A-CE759E26A72CQ37610660-6EED4B8F-C031-4848-9A02-E25AAB446DA6Q37637067-DB631B61-151A-4533-A7C0-BD5DA095DF25Q38147723-254E8980-3FE9-419B-A8E8-007C264FCE53Q38196457-5307A67D-1F36-48E6-86FD-93272742EE23Q38226696-975F6553-90DE-4C91-8313-3B882E112D58Q38967866-ACF7BCC3-8156-4158-AEF6-CC7680813773Q39536633-C34A5D55-CB99-4730-9738-F90F1488C81FQ39549270-A38FA354-AA39-4902-94BF-DDCE909A77BCQ41967834-5E096113-F425-43E3-9938-0714277218C2Q42254682-25FA7AB4-E3C7-49EE-928A-1FA597D320F3Q42532116-9D1F7200-0D33-4DEC-AD6D-72FE92C7450CQ46499496-2B3D25E5-B18A-44E4-955A-0FC8F6EF6CF9Q47569409-43D96EAD-AA75-46B6-9EE4-5637A7A6F685Q56792140-C29CD22A-8405-4486-AFF0-EAD09BA07877
P2860
A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@ast
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@en
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@nl
type
label
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@ast
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@en
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@nl
prefLabel
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@ast
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@en
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@nl
P2093
P2860
P1433
P1476
A genotypic test for HIV-1 tro ...... treatment-experienced patients
@en
P2093
Douglass S Chapman
Erik P Johnson
Jamie L Platt
Martin Siaw
Pinaki Biswas
Rick L Pesano
Ron M Kagan
Zhaohui Su
P2860
P304
P356
10.1371/JOURNAL.PONE.0046334
P407
P577
2012-09-27T00:00:00Z